NDC 79903-076-43 - Sinus Congestion PE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79903-076
- Requested NDC
- 79903-076-43
- Package NDCs from labels
- 79903-076-43, 79903-076-24, 79903-076-23
- Manufacturer
- WALMART INC. | LNK International, Inc.
- Effective date
- 2025-07-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Equate 44-453 | WALMART INC. | LNK International, Inc. | 2025-07-21 | HUMAN OTC DRUG LABEL |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2026-10-28 | Warnings | B22547B95K |
| Blue Lizard Sensitive SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 32d78048-d281-1d80-e063-6394a90aec19 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 32W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eed2165-afc2-6958-e063-6294a90add58 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 34O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eedd87b-a7b1-1abc-e063-6294a90ae29e | 2026-10-28 | Warnings | 15FIX9V2JP |
| Gencare-Nasal Decongestant PE | PHENYLEPHRINE HYDROCHLORIDE | Pioneer Life Sciences, LLC | ad4d74a8-a762-4378-9016-f7c83421073e | 2026-10-28 | Warnings | 04JA59TNSJ |
| QUALITY CHOICE | PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | 14596551-dd82-46b3-8eb8-e69efaea105b | 2026-10-27 | Warnings | 04JA59TNSJ |
| HISTEX-DM | DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 836d062c-29f0-4fd7-b65c-771a3bbd52c4 | 2026-10-26 | Warnings | 04JA59TNSJ |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | 04JA59TNSJ |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | 15FIX9V2JP |
| NASAL and SINUS DECONGESTANT | PHENYLEPHRINE HYDROCHLORIDE | JHK Inc dba American Safety & First Aid | 63e51305-2575-49c4-9fda-7b3e1b4b6ede | 2026-10-26 | Warnings | 04JA59TNSJ |
| Heparin Sodium in Dextrose | HEPARIN SODIUM AND DEXTROSE | B. Braun Medical Inc. | 92a6f533-1a3d-4734-b413-d245592454e3 | 2026-10-26 | Warnings, Adverse reactions | LX22YL083G |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.